TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
0 hedge funds and large institutions have $0 invested in TrovaGene, Inc. Warrant in 2017 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $68K → $0 (-$68K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $25K
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$67K |
| 2 |
Morgan Stanley
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Millennium Management
New York
| – | -$67K | -489,900 | Closed |
|
|
2
Morgan Stanley
New York
| – | -$1K | -8,400 | Closed |
|
TROVW Hedge Fund Activity: Q2 2017 in Review
0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q2 2017, worth a combined $0 — down 100% from $68K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TROVW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Millennium Management, exiting entirely with an estimated $67K sold.
- 0 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q2 2017, down from 3 in Q1 2017.
- Funds reported $0 of TrovaGene, Inc. Warrant stock for Q2 2017, down 100% quarter-over-quarter.
- 0 funds opened new TrovaGene, Inc. Warrant positions in Q2 2017 and 3 closed out, a net change of -3 holders.
- The largest TrovaGene, Inc. Warrant seller in Q2 2017 was Millennium Management, an estimated $67K sold.
Based on aggregated 13F filings for Q2 2017.